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Chapter 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 The Endoplasmic Reticulum and Protein Quality Control 
 
The endoplasmic reticulum (ER), a eukaryotic cellular organelle, composed of 
interconnected flattened sacs and tubules that is located in between the outer 
nucleus membrane and the Golgi. The main function of ER includes protein quality 
control and folding, and lipid metabolism, which are carried out by rough ER (RER) 
and smooth ER (SER), respectively. 
 The RER facilitates the folding of all secretory and membrane proteins, which 
include approximately one third of cell’s total proteins (Brodsky and Wojcikiewicz, 
2009). After being co-translationally transported into RER, nascent proteins then 
become fully folded, modified and transported to their destined locations. This 
process is tightly regulated by quality control machineries to ensure the homeostasis 
of the cell and the organism.  
Nascent proteins enter the ER through a narrow, heterotrimeric channel called 
Sec61 complex (Matlack et al., 1998). For glycosylated proteins, a preassembled 
oligosaccharide core N-acetinglucosamine2-mannose9-glucose3 Glc3Man9GlcNAC2 
(N-linked oligosaccharides or N-glycan), derived from dolichol-PP, a lipid 
pyrophosphate donor on the ER membrane, is immediately added at Asn-X-Ser/Thr 
asparagine (ASN) motifs of nascent proteins by oligosaccharyltransferase (OST) 
(Parodi, 2000), (Parodi et al., 1972). The addition of N-linked oligosaccharides 
triggers the trimming of the two outermost glucose units by α-glucosidases I and II, 
leaving a N-glycan structure that can be recognized by two homologous ER lectin 
chaperones, calnexin (CNX) and calreticulin (CRT). CNX-CRT, along with an 
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oxidoreductase ERp57, interacts with glycoproteins to aid their proper folding as 
well as disulfide bond formation (Coe and Michalak, 2010). For well-folded 
glycoproteins, glucosidase II cleaves the last glucose unit, lowering the affinity and 
allows proteins to be released by CNX-CRT, where they can be transported to the 
Golgi compartment and are further modified (Malhotra and Kaufman, 2007; Molinari, 
2007). Misfolded or unfolded glycoproteins, however, are recognized and re-
glucosylated by ER folding sensor UDP-glucose:glycoprotein  glucosyltransferase 
(UGT1), which allow them to stay a few more cycle of CNX-CRT and assisted for 
forming their protein structures (Pearse et al., 2010). If failed to achieve their 
destined structure, O-mannosylation is added onto the proteins by 
phosphoethanolamine N-methyltransferase 1 and 2 (Pmt1/Pmt2), which serve as a 
degradation marker to prevent overuse of chaperones and inhibits aggregation (Xu 
et al., 2013). These glycoproteins will eventually be cleared by ER-associated 
degradation (ERAD), a process that will be discuss in details in 1.2.  
In contrast to glycoproteins, nascent non-glycosylated proteins are thought be 
assisted by a complex involving protein disufide isomerase (PDI), one of the first-
identified thiol-disulfide oxidoreductases (Ferrari and Soling, 1999; Freedman et al., 
2002), and binding immunoglobulin protein (BiP), a chaperone that protects 
immature protein from aggregation by binding to extended hydrophobic domains of 
nascent proteins (Hebert and Molinari, 2007).  If proteins are properly folded, 
nonglycosylated proteins will be transported to the Golgi, similar to that of 
glycosylated proteins. If not, nonglycoproteins will be transported to ERAD complex 
by ATP-hydrolysis-powered BiP for degradation. Prior to the degradation, disulfide 
bonds of the misfolded non-glycosylated proteins will be cleaved by ERdj5, a protein 
with reductase activity at its C-terminus (Ushioda et al., 2013).     




1.2 ER Associated Degradation (ERAD) – The Sel1L-Hrd1 Complex 
 
While properly folded glycosylated proteins and nonglycosylated proteins 
leave the ER through COP-II coated vesicles, misfolded or unfolded proteins are 
retained in the ER and targeted for proteasome degradation, a process called ERAD. 
ERAD centers on an E3 ubiquitin ligase, which possesses variable number of 
transmembrane domains and a cytosolic RING finger domain and catalyze substrate 
ubiquitination. E3 ligase, together with multiple cofactors, forms an ERAD complex. 
ERAD complexes are responsible for substrates recognition, translocation and 
ubiquitination. In both yeast and mammalian systems, each E3 ligase predominantly 
degrades a specific subset of substrates, ranging from substrates with ER luminal, 
cytosolic and/or membrane lesions (Smith et al., 2011); however, studies have 
shown that overlap of substrate specificities occur in both mammals and yeast.    
Yeast contains two ubiquitin ligases, Doa10 and Hrd1p, and both contain 
large multispanning membrane domains (Mehnert et al., 2010). Hrd1p interacts with 
both substrates with membrane or luminal lesions and ERAD components on the 
luminal side, while promotes polyubiquitination and the delivery of substrates on the 
cytoplasmic side (Mehnert et al., 2010). Hrd1p associates with substrate recruitment 
factor Hrd3p, the ubiquitin-conjugating enzyme Ubc7, as well as Cdc48p ATPase 
(Gauss et al., 2006b). Kar2p and Yos9p are two chaperones binding to substrates 
and are in association with Hrd1p. Yos9p was shown to bind to glycosylated 
substrates at its MRH domain and form a complex with BiP, thus defining substrates 
of Hrd1p (Carvalho et al., 2006; Denic et al., 2006; Hosokawa et al., 2001). In fact, 
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both Yos9 and Hrd3p serve as “gatekeepers” in recognizing substrates (Ismail and 
Ng, 2006).  In addition, the degradation of all soluble, luminal proteins also depends 
on the binding of a small integral protein Der1 to Hrd1p via Usa1p (Carvalho et al., 
2006; Horn et al., 2009). The Doa10 ligase removes ER-membrane proteins with 
cytoplasmic lesions, while whether it also removes soluble proteins remain 
controversial (Kaufman et al., 2002; Mehnert et al., 2010). In order to degrade 
proteins, the Doa10 complex requires ubiquitin-conjugating enzyme Ubc6, Ubc7, 
along with Ubc cofactor Cue1 and Cdc48p ATPase complex (Ismail and Ng, 2006; 
Kaufman et al., 2002).         
To date, many distinct ERAD pathways have been found in the mammalian 
system, such as HMG-CoA reductase degradation protein 1 (Hrd1), glycoprotein 78 
(Gp78), Kf-1 and TRC8 (Maruyama et al., 2008; Mehnert et al., 2010; Stagg et al., 
2009). Yet, only Hrd1 and Gp78 were studied in details, and several exogenous and 
endogenous substrates were identified in each pathway ((Hirsch et al., 2009). Hrd1 
is the mammalian homolog of Hrd1p in yeast, which form a stoichiometric complex 
with sel-1 suppressor of lin-12-like (Se1lL), the mammalian homolog of Hrd3p, for its 
own stability and for substrate recognition. Chaperones and lectins also recognize 
specific subset of substrates and deliver them to either Hrd1 or Sel1L for 
degradation. 
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           Hebert. D.N., Bernasconi. R., & Molinari. M. (2009). Seminars in Cell & Developmental Biology 
 
 
In details, substrates are proteins that have lesions or fail to achieve their 
native states. When glycosylated proteins/substrates fail to form their proper 
structures, they are removed from CNX-CRT cycle by mannosidases and/or ER 
degradation enhancer, mannosidase alpha like (EDEM), enzymes that can remove 
sugar units. EDEM interacts with CNX and possibly receives glycosylated substrates 
during their interaction (Hirao et al., 2006; Hosokawa et al., 2001; Mast et al., 2005; 
Molinari et al., 2003; Oda et al., 2003; Olivari et al., 2005). Sequentially, substrates 
are transferred to osteosarcoma amplified 9 (OS9)/transactivated gene B protein 
(XTP3B), which are mammalian homologs of Yos9. Interestingly, OS9 and XTP3B 
seem to have different functions from one another. While OS9 interacts with 94 kDa 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   8	  
glucose-regulated protein (GRP94) and Sel1L (Christianson et al., 2008), XTP3B 
forms a complex with BiP and interacts with Se1L-Hrd1 complex (Hosokawa et al., 
2008). Nevertheless, both lectins deliver glycosylated substrates to the Sel1L-Hrd1 
complex. In contrast to glycosylated substrates, non-glycosylated substrates are 
recognized by BiP, followed by the cleavage of disulfide bound by ERdj5. After ATP 
hydrolysis, BiP delivers substrates to Homocysteine-responsive endoplasmic 
reticulum-resident ubiquitin-like domain member 1 protein (Herp) complex that 
composed of p97 ATPase, Hrd1, Sel1L and Derlin-1 (Ushioda et al., 2013).    
Substrates are then translocated through a channel from ER to cytosol. 
Previously, Sec61 was thought to be the channel for the translocation of substrates. 
However, it was shown under real-time fluorescence that ERAD substrates were 
retained in the ER when Derlin-1, the homolog of Der1 in yeast was blocked, but not 
when Sec61 was blocked (Wahlman et al., 2007). Hence, Derlin-1 now is considered 
as the most possible channel for the retrotranslocation. Derlin-1 associates with 
different substrates and interacts with VIMP that recruits the p97 ATPase and its 
cofactors (Ye et al., 2004). Ubiquitination are thought to be occurred on the cytosolic 
domain of substrates once they enter the channel, which is carried out by an E1 
ubiquitin-activating enzyme, E2 ubiquitin-conjugating enzyme and the E3 ligase 
(Richly et al., 2005). The ring domain on Hrd1 and other E3 ligases add ubiquitin 
(Ub) to substrates powering by ATPase P97. After translocation and 
polyubiquitination, substrates are finally degraded by cytosolic 26S proteasome. 
Deubiquitination is also required in the process of dislocation (Ernst et al., 2009).  
 
1.3 The IRE1α-XBP1 pathway of the Unfolded Protein Response 
(UPR) 
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Dysfunction of ERAD leads to the accumulation of misfolded proteins, 
leading to ER stress and unfolded protein response (UPR), which include three 
major ER-to-nucleus signaling pathways (Shen et al., 2004). Unlike ERAD that 
operates in both normal and stress conditions, UPR is activated only in stressed 
state. Three UPR pathways, the inositol-requiring protein-1 (IRE1α), activating 
transcription factor-6 (ATF6) and protein kinase RNA-like ER kinase (PERK) 
pathways work synergically to first reduce protein load in the ER, then increase 
capacity of the ER to handle unfolded proteins, and finally trigger cell death if ER 
stress becomes irreversible (Ron and Walter, 2007). IRE1α is a bifunctional 
transmembrane kinase and endoribonuclease that is activated through 
autophosphorylation and oligomerization under ER stress (Ron and Walter, 2007). 
Activated IRE1α cleaves a unique mRNA called X-box binding protein 1 
(XBP1/XBP1u) in metazoans, which cause the excision of an intron and lead to a 
spliced, lower molecular weight mRNA XBP1s. XBP1s is a transcription factor that 
targets a diverse ranges of genes, including ER chaperones and ERAD components, 
tissue specific metabolic genes, disease-associated genes and so on (Acosta-Alvear 
et al., 2007). Thus, the activation of IRE1α enhances protein-folding capacity of the 
ER and alleviates ER stress; ATF6 is an ER-membrane embedded transcription 
factor that pinched off and transported through vesicle upon ER stress. In there, 
ATF6 is cleaved sequentially by site-1 and site-2 proteases (S1P and S2P) (Haze et 
al., 1999; Ye et al., 2000), leaving a N-terminal domain (ATF6N) that is translocated 
to the nucleus and up-regulates UPR genes such as BiP, Grp94 and PDI (Walter 
and Ron, 2011). Similar to the activation of IRE1α, the last UPR sensor PERK is 
activated by autophosphorylation and oligomerization (Kebache et al., 2004). Unlike 
IRE1α, PERK inhibits the potent translation initiation factor eukaryotic translation 
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initiation factor-2 (eIF2α), thus inhibiting translation and protein load in the ER 
(Ron and Walter, 2007). 
Although both ERAD and UPR are powerful tools cells utilize to relief ER 
stress, they can be insufficient in the presence of severe ER stress. In this condition, 
cell death will be triggered. Under prolonged and severe ER stress, calcium is 
transferred from ER to mitochondria mainly through ligand-gated calcium channel 
called inositol 1,4,5-triphosphate receptors (IP3Rs), initiating a calcium-dependent 





OS9 is a mammalian lectin in the ER lumen that contains Mannose-6-
phosphate receptor homology (MRH) domain and is an important component of the 
Sel1L-Hrd1 ERAD complex (Hosokawa et al., 2010a). OS9 mRNA is expressed 
ubiquitously and is amplified in sarcomas (Hosokawa et al., 2010a). Human OS9 has 
four variants as a result of alternative splicing: full-length version of the protein 
OS9.1 comprises 667 amino acid; OS9.2 lacks exon 13 and is 55 amino acid shorter 
with a glutamate to glycine conversion in the splice region; OS9.3, which is 70 amino 
acid shorter than the full length, lacks exon 13 and last part of exon 11; OS9.4 lacks 
final part of exon 11 only and is 15 amino acid shorter (Kimura et al., 1998). 
However, only OS9.1 and OS9.2 have been observed in human/mice cell lines and 
tissues (Bernasconi et al., 2008). Interestingly, reverse transcription (RT) and 
quantitative polymerase chain reaction (qPCR) analysis revealed that the transcripts 
of OS9.1 at normal cellular state are significantly lower than those of OS9.2 in both 
mouse embryonic fibroblasts (MEF) and human embryonic kidney 293 T cells (HEK 
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293T) (Bernasconi et al., 2008). It also has been reported that the transcription of 
OS9 gene is induced upon ER stress (Bernasconi et al., 2008). 
 OS9, as well as its yeast homolog Yos9, has been identified to deliver 
substrates, especially luminal glycosylated substrates to the Sel1L-Hrd1/Hrd3p-
Hrd1p complex for degradation (Hosokawa et al., 2010a). The substrate recognizing 
ability of OS9 lies in its MRH domain, which is homologous to mannose-6-phosphate 
receptors (MPRs) (Munro, 2001). Both cation-dependent (CD-MPR) and cation-
independent MPRs (CI-MPR) recognizes terminal mannose-6-phosphate (M6P) on 
the N-linked glycans of lysosomal enzymes (Satoh et al., 2010), which lead to the 
recognition that proteins containing an MRH domain are lectins that have sugar 
(glycan) binding ability (Hosokawa et al., 2010a). Alignment of Yos9, OS9 and 
XTP3B, another homolog of Yos9 found in mammals, revealed that several amino 
acid and six cysteine residues are well conserved; yet, only two of the six interact 
with mannose in CD-MPR (Roberts et al., 1998). Despite the N-terminal of MRH 
domains of Yos9 and OS9 share 20% identity, they only share 12% overall identity, 
suggesting only the functional part of MRH has been well conserved (Friedmann et 
al., 2002). Crystallized human OS9 MRH domain showed that OS9 has a flattened 
B-barrel structure with a P-type lectin fold and contains a double tryptophan residues 
at its 117 and 118 position, which resides in its sugar binding site (Satoh et al., 
2010). The same study showed that this double trypophan motif (WW) recognizes 
specific trimmed-glycan structure presented on misfolded glycoproteins, allowing 
OS9 to bind and sequentially deliver substrates to the ERAD complex (Satoh et al., 
2010). 
Yos9 in yeast is a luminal membrane-associated ER protein that is required 
for the degradation of glycosylated proteins, but not non-glycosylated proteins in 
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yeast (Munro, 2001). The lectin domain of Yos9 is required for its interaction with 
substrates (Gauss et al., 2006a; Kim et al., 2005), but not for its interaction with the 
ERAD complex. Yos9 interacts with a well-defined ERAD glycosylated substrate 
carboxypeptidase Y (CPY) only when CPY is misfolded (Munro, 2001); however, this 
interaction was abolished when MRH domain of Yos9 was deleted. It is also found 
that without MRH domain, misfolded CPY was retained in the ER instead of being 
degraded, suggesting the MRH domain of Yos9 is needed for the delivery of 
misfolded glycoproteins to the Hrd1p-Hrd3p ERAD complex. Despite the deletion of 
MRH abolish the interaction of Yos9 and substrates, it does not affect the interaction 
of Yos9 and Hrd3p (Gauss et al., 2006a) The question then lies at how Yos9 interact 
with the complex. Following study confirmed that Yos9 physically interact with the 
last TPR triplet of Hrd3p, but does not directly interact with Hrd1p (Gauss et al., 
2006b). It has been proposed that Yop9 confirms the misfolding state of substrates 
before handing them to the ERAD complex by proofreading the exposed 
hydrophobic residues on the surface of substrates (Munro, 2001), thus acting as a 
“gatekeeper” to ensure quality of ERAD.               
Although Yop9 is well characterized in yeast, mammalian OS9 in ERAD is 
less clear and more controversial. First of all, the two variants of OS9, OS9.1 and 
OS9.2, seem to have its own special function and effect, apart from their common 
function. From the observation in our laboratory, the protein level of the two variants 
changes by unknown variable in both MEF and HEK 293T cells, despite the level of 
OS9.2 transcripts is higher in both cell lines (Bernasconi et al., 2008). Functionally, it 
has been shown that when Sel1L is silenced by RNAi, substrate BACE476 delta 
binds specifically to OS9.1, but not OS9.2. RNAi silencing of both OS9.1 and OS9.2 
delays the clear of substrate NHK, but not when only OS9.1 is silenced. Sucrose 
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gradient analysis also suggested OS9.2 preferentially binds to Sel1L (Hosokawa 
et al., 2010b). Secondly, confusing results have been found when OS9.1 is knocked-
down or overexpressed. While knock down of OS9 delays degradation of human α1-
antitrypsin variant null Hong Kong (NHK) (Bernasconi et al., 2008; Christianson et 
al., 2008), it does not affect the degradation of several other ERAD substrates such 
as RI332 (Christianson et al., 2008). Overexpression of OS9 instead of facilitating 
the degradation of substrates, were found to either delay the degradation of 
substrates RI332 or NHK (Bernasconi et al., 2008; Mueller et al., 2008), (Mueller et 
al., 2008) or remain HNK in the ER (Christianson et al., 2008). Recent studies have 
shown that both OS9 and XTP3B are required for the degradation of soluble ERAD 
luminal substrates BACE and CD3 without transmembrane domains, since the 
knockdown of either OS9 or XTP3B does not affect degradation while the knock 
down of both blocks it (Bernasconi et al., 2010).  
Moreover, how OS9 interact with the ERAD complex and deliver substrates to 
the complex remind unclear. Thus far, two main models have been suggested. One 
model suggests that OS9 and XTP3B stably incorporated in the complex through 
stably interacting with Sel1L. In this model, MRH of OS9 recognizes trimmed N-
glycan on misfolded glycoproteins that are in proximity with OS9 (Munro, 2001). In 
the other model, OS9-GRP94 forms a complex in the ER lumen and actively 
recognizing misfolded glycoproteins, followed by delivering substrates to ERAD 
complex. The interaction of OS9 with the complex in this model is dynamic rather 
than stable (Munro, 2001). Further studies are needed to confirm how OS9 deliver 
substrates. Just like in yeast, OS9 has been shown to interact with Sel1L. Latest 
study found that OS9 has reduced interaction with Sel1L when the MRH domain 
activity is abolished in OS9, suggesting that besides interacting with Sel1L on its 
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MRH domain, OS9 also interact with Se1lL on other residues (Hosokawa et al., 
2009). In concordance, our data also showed that nonglycosylated Sel1L interests 
with OS9.   
Analysis of Yos9 and OS9 revealed the role of both lectins in ERAD. The 
MRH domain of OS9 is needed for the recognition and the degradation of certain 
ERAD substrates, but is not required for its interaction with Sel1L. However, how 
OS9 delivers substrates, the classes of substrates as well as the function of its 
variants remain controversial. Hence, more future studies are needed to understand 
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Chapter 2: ER STRESS INDUCES OS9 DEGRADATION VIA THE 
SEL1L-HRD1 ERAD COMPLEX 
 
2.1 Abstract  
 
Misfolded or unfolded proteins generated by inefficient protein folding or ER 
stress is translocated from the ER to cytosol for proteasome degradation, a process 
termed endoplasmic reticulum associated degradation (ERAD). OS9, a lectin protein, 
has been shown to deliver misfolded or unfolded glycoproteins to the most 
conserved ERAD complexes in the mammalian system, the Sel1L-Hrd1 ERAD 
complex (Mehnert et al., 2010). Our study on OS9 shows that despite being an 
effector of the complex, OS9 itself is degraded by the same complex in response to 
ER stress. OS9 protein level decreases drastically upon the treatment of 
Tunicamycin (TM), Thapsigargin (Tg) or Dithiothreitol (DTT) . The addition of MG132 
completely blocked the degradation, showing OS9 is degraded by proteasome. We 
then show the degradation of OS9 is abolished in Hrd1 knock-out (Hrd1-/- ) MEF 
cells, and significantly attenuated in Sel1L-/- cells when cells were treated with 6hr of 
cycloheximide (CHX), suggesting both Sel1L and Hrd1 are required for the 
degradation of OS9, but Hrd1 plays a more important role in the process. We also 
find that the protein level of OS9 is significantly higher in Sel1L-inducible knock out 
(IKO) mice than in WT mice, confirming that OS9 is degraded by Sel1L-Hrd1 
complex in vivo. Using co-immunoprecipitation (CO-IP), we find that Sel1L 
associates with OS9 in a glycosylation independent manner and that it can be 
ubiquitinated by overexpressed Hrd1. In addition, our data suggest the protein 
stability of OS9 is mediated through the XBP1-Hrd1 axis. These data suggest that 
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OS9 is degraded through the Sel1L-Hrd1 complex under ER stress. Not only does 
this study identifies a potential endogenous substrate of the Sel1L-Hrd1 complex, 
given the fact that OS9 is an effector of the complex, this study may also provide 
insights into a possible self-regulatory mechanism of the complex through regulating 
OS9.   
 
2.2 Introduction  
 
 The ER is the major site for the synthesis of membrane proteins as well as 
proteins destined to the secretory pathway. To monitor protein quality, folding of 
nascent polypeptides in the ER is tightly controlled by several cellular mechanisms. 
Terminally misfolded and unfolded proteins (substrates) are degraded by ERAD, a 
conserved process characterized by the recognition and translocation of substrates, 
followed by the degradation by cytosolic proteasome (McCracken and Brodsky, 
1996). 
ERAD is centered on E3 ligases, which are proteins that facilitate the 
polyubiquitination of substrates. Since only polyubiquitinated substrates can be 
recognized and degraded by cytosolic proteasome, E3 ligases serve an essential 
role in this process (Smith et al., 2011). To date, the best characterized and the only 
conserved E3 ligase in mammalian system is Hrd1 (Iida et al., 2011). Hrd1 physically 
associates with Sel1L (Lilley and Ploegh, 2005), a critical adaptor protein of Hrd1, 
and Hrd1-Sel1L forms a stable transmembrane ERAD complex by interacting with 
Derlin 1&2, chaperones such as OS9, p97/VCP and Herp (Lilley and Ploegh, 2005).  
In order for degradation to occur, stringent and accurate substrate recognition 
and delivery system must present. OS9, a lectin protein that processes MRH 
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domain, plays an important role in recognizing misfolded glycoproteins and bring 
them to the Sel1L-Hrd1 complex. It is proposed that the MRH domain of OS9 
recognizes and binds to specific sugar units on substrates that are partially 
processed by other chaperones such as EDEMs (Christianson et al., 2008). Since 
OS9 is shown to physically associate with Sel1L (Christianson et al., 2008), it is 
believed that OS9 delivers substrates to the Sel1L-Hrd1 complex through their 
interaction (Christianson et al., 2008). However, whether OS9 stably interacts with 
Sel1L remains unclear (Hosokawa et al., 2009). Understanding recognition pathways 
throw lights on the identification of substrate classes and the actual endogenous 
substrates, especially when only a few endogenous substrates of the Sel1L-Hrd1 
complex have been identified thus far.  
In this study, we used Hrd1-/-/Sel1L-/- MEF cells and ER stress inducing drugs 
to study the dynamic of OS9 under those conditions. Our data suggest that OS9, 
despite being part of the Sel1L-Hrd1 complex, is an endogenous substrate of the 
exact same complex.  
 
2.3 Experimental Procedures  
 
Cell lines and reagents. Hrd1-/- MEF cells were generous gift from Dr. 
Hosokawa of Kyoto University. Sel1L-/- MEF cells were generous gift from Dr. 
Qiaoming Long of Cornell University. HEK 293T an MEF cells were maintained in 
DMEM supplemented with 10% FBS (Hyclone) and 1% penicillin/streptomycin. TM, 
MG132 and stock CHX (Sigma) were dissolved in DMSO and ethanol, respectively. 
Cells were treated with TM at 2.5µg/ml for 4.5 hrs and immediately snap-frozen in 
liquid nitrogen.   
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 Site-directed mutagenesis. Site-directed mutagenesis to generate Sel1L 
Arginine (N) to Glutamine (Q) single mutants at residues 191, 213, 269, 427, 604, 
respectively and Sel1L non-glycosylated mutant (N5Q) at all five residues were 
performed using pcDNA3/GFP-Sel1L as template (see supplement for primer 
sequences). The PCR included mutagenic primers, as well as Pfu polymerase 
(Stratagene) and the program consisted of 16 cycles of 95◦C for 30sec, 55◦C for 30s 
and 72◦C for 5 min. After DpnI digestion for 2-3 hr, the PCR product was transformed 
into XL-Blue competent cells by incubating PCR products with the cells for 10 min, 
followed by a heat-shock at 42◦Cfor 30sec. All mutations were confirmed by DNA 
sequencing. 
Transfection and immunoprecipitation. HEK 293T were plated on to 10-
cm-diameter dishes the day before transfection. Transfection was performed by 
preparing polyethylenimine (PEI, Sigma) (1mg/ml in 0.9% NaCl) with plasmids at 5:1 
(µl/ug) ratio and adding to the cell culture. Transfected cells were using Triton X-100 
reagent as previous described (Chen and Qi, 2010).  Anti- Flag agarose beads 
(Sigma-Aldrich) were added to the supernatants and rocked gently at 4◦C overnight. 
Following 4-6 times wash with washing buffer [20mM Tris/HCl, pH7.5, 137mM NaCl, 
1% (v/v) Triton X-100, 2mM EDTA and 10% (v/v) glycerol], the beads were boiled 
and analyzed by Western Blotting.  
Western Blotting. Western blotting was performed using 10-20ug of total cell 
lysates. Antibodies used in this study: HSP90 (rabbit, 1:6000), FLAG-HRP from 
Santa Cruz; Sel1L (rabbit, 1:2000), OS9 (rabbit, 1:5000) from Abcam; Hrd1 (rabbit, 
1:8000) from Novus Biologicals; Calnexin (rabbit, 1:10000) from Assay Design. Band 
density was quantified using the Image Lab software on the ChemiDOC XRS+ 
system (Bio-Rad). 
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RNA extraction, RT and q-PCR.  Total RNA of mice tissues and cells 
were extracted using TRIzol reagent as previously described (Sun et al., 2014) and 
reverse transcribed using the Superscript III kit (Invitrogen). cDNAs were analyzed 
using the SYBR Green PCR system on the Roche LightCycler 480 machine. All 
quantitative PCR (qPCR) data were normalized to ribosomal l32 gene in the 
corresponding sample.   
Statistical Analysis. Results are expressed as mean ± SEM. Comparisons 
between groups were made by unpaired two-tailed Student t test, where P<0.05 was 
considered as statistically significant. 
 
 
2.4 Results  
 
ER Stress Induces OS9 Degradation.  
To examine the protein stability of OS9 under ER stress, we treated MEF cells 
with ER stress inducer TM, a drug that blocks glycosylation. Drug treatment revealed 
that while Sel1L and Hrd1 remain stable upon 4 hr of TM treatment, OS9 levels were 
largely reduced (Fig. 2.1A and B). The reduction was more pronounced in OS9.2, in 
which the protein level decreased by 70% (Fig.2.1A and B), indicating OS9 is less 
stable than Sel1L and Hrd1, and is subject to degradation under ER stress. 
Interestingly, this effect was completely blocked by the addition of MG132, a 
proteasome inhibitor (Fig, 2.1A), suggesting OS9 is degraded by proteasome. In 
order to verify the effect of OS9 degradation was not drug-specific, we treated MEF 
cells with other classes of ER stress inducers, namely Tg that blocks Ca2+ ATPase, 
and DTT that blocks disulfide bond formation. As expected, both Tg and DTT 
induced the degradation of OS9, and the effects were reversed by the co-addition of 
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MG132 (Fig. 2.1 C and D). However, Our data suggested OS9 respond differently 
with different classes of drugs (Fig. 2.1 C and D). Also, OS9.2 was more affected 
than OS9.1 in all three cases, hinting that OS9.2 is either less stable than OS9.1, or 
it may more likely to be associated with the Sel1L-Hrd1 complex, as previously 
reported (Hosokawa et al., 2010a). 
 
Figure 2.1. ER stress induces OS9 degradation. (A) Western blot analysis of OS9, 
Sel1L and Hrd1 in MEF cells that were either untreated (Con), treated with MG132, 
treated with 2.5ug/ml TM or treated with TM and MG132 for 4 hr. Quantitation of 
OS9 upon being normalized to the loading control HSP90 were shown under 
western blot of OS9 as indicated. OS9 protein levels in untreated samples, TM 
treated samples, and TM+MG132 treated samples were presented in bar graph in 
(B) as ‘Con’, ‘TM’ and ‘TM+MG132’ respectively.  (C) Western blot analysis of OS9, 
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Sel1L and Hrd1 in MEF cells that were either untreated (Con), treated with 
MG132, treated with 300ng/ul Tg, treated with 1mM DTT, treated with Tg and 
MG132 or treated with DTT and MG132 for 4hr. OS9 protein levels in untreated 
samples, Tg treated samples and Tg + MG132 treated samples were quantified in 
bar graph shown in (D); OS9 protein levels in untreated samples, DTT treated 
samples, and DTT + MG132 treated samples were also quantified in separate bar 
graph shown in (D).   
 
 
OS9 Degradation Is Mediated by the Sel1L-Hrd1 ERAD Complex in Vitro.  
We next asked whether the degradation of OS9 is mediated by the Sel1L-
Hrd1 complex. In Hrd1-/- MEF cells, the protein levels of both Sel1L and OS9 were 
increased at basal level comparing to those of wide type (WT) MEFs (Fig. 2.2A). The 
basal level of both OS9.1 and OS9.2 increased by almost 2 fold in Hrd1-/- cells (Fig. 
2.2B), while the mRNA only increased for 50% (Fig.2.2C), pointing that the increase 
in OS9 protein level was partly due to post-transcriptional regulation. This supports 
our hypothesis that OS9 is degraded by the Hrd1 complex. Interestingly, the protein 
level of Sel1L also had 2 fold increase in Hrd1-/- cells (Fig, 2.2B). Upon the induction 
of cell death by adding CHX to WT, Se1lL-/- and Hrd1-/- cells, we found that the 
degradation of OS9 was attenuated in Sel1L KO cells and was completely abolished 
in Hrd1 KO cells (Fig. 2.2D and E). These data suggested that OS9 is indeed 
degraded by the Sel1L-Hrd1 ERAD complex.  
A recent study from our laboratory demonstrated that Sel1L regulates the 
stability of Hrd1 (Sun et al., 2014), just as the situation in yeast (Kaneko et al., 2012). 
Consistently, our data showed that Hrd1 was much less stabled and drastically 
reduced in Sel1L-/- cells (Fig.2.2D). The remained Hrd1 in Sel1L-/- cells might explain 
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the observation that OS9 was still subject to degradation under CHX chase 
experiment in the absence of Sel1L.  
 
Figure 2.2. OS9 degradation is mediated by the Sel1L-Hrd1 complex in Vitro. 
(A) Western blot analysis of OS9, Hrd1 and Sel1L in untreated WT and Hrd1-/- MEF 
cells with quantitation shown in B. (C) qPCR analysis of OS9 in WT and Hrd1-/- MEF 
cells. (D) OS9 half-life analysis in MEF cells treated with CHX at time 0, 1, 3 and 6hr. 
Darker exposure of OS9 blot is included to show the levels of OS9.1. Quantitation 
shown in (E) upon normalization to the loading control HSP90. 
 
 
OS9 Degradation Is Mediated by the Sel1L-Hrd1 ERAD in Vivo.  
To determine the effect of ERAD deficiency on the degradation of OS9 in vivo, 
we next analyzed OS9 protein levels in recently generated tamoxifen-inducible 
knockout mice (IKO) (Sun et al., 2014).  Indeed, in line with those in vitro findings, 
OS9 protein levels were significantly elevated in tissues lacking Sel1L such as the 
pancreas, ileum and kidney (Fig 2.3 A-C). The mRNA level of OS9 was decreased in 
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IKO mice (Fig 2.3 D), providing further support to the notion that Sel1L controls 




Figure 2.3. OS9 Degradation Is Mediated by the Sel1L-Hrd1 ERAD in Vivo. (A-C) 
Western blot analysis of Sel1L, Hrd1 and OS9 in pancreas (A), ileum (B) and kidney 
(C) from WT and IKO mice. Quantitation of OS9 upon being normalized to the 
loading control HSP90 were shown under western blot of OS9 as indicated. (D) 
qPCR analysis of OS9 in the kidney of WT and IKO mice.  The data is a courtesy of 
Iris Sun and Dr. Guojun Shi in the Qi laboratory. 
 
 
OS9 Interacts With Sel1L In a Glycosylation Independent Manner. 
 Previous studies have shown that OS9 physically interacts with Sel1L 
(Christianson et al., 2008; Hosokawa et al., 2010a; Satoh et al., 2010), however it 
remains unclear whether the interaction is glycosylation dependent. To this end, we 
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first performed transfection in HEK293T cells to demonstrate that both isoforms of 
OS9 (OS9.1 and OS9.2) interacted with Sel1L (Fig. 2.4A and B). 
To assess whether their interactions are glycosylation dependent, we 
generated a Sel1L mutant with no potential glycosylation sites (Sel1L N5Q). IP data 
showed that both Sel1L and Sel1L N5Q readily interacted with OS9 (Fig.2.4C), 
suggesting that Sel1L interacts with OS9 independently of glycans on Sel1L protein.   
 
 
Figure 2.4. Physical interactio between OS9 and Sel1L, and ubiquitination of 
OS9.  (A) Inmunoprecipitation and Western blot analyses of the interactions between 
(A) Sel1L and OS9.1, (B) Sel1L and OS9.2, and (C) Sel1L N5Q and OS9.1, in 
HEK293T cells transfected with different combinations of plasmids as indicated. (D-
E) Inmunoprecipitation and Western blot analyses of ubiquitination of OS9 in 
HEK293T cells transfected with different combinations of plasmids as indicated. 
MG132 were added to the cells 2 or 4 hr before harvesting.        
 
OS9 Is Ubiquitinated by Hrd1 
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 Hrd1 is an E3 ligase that ubiquitinates substrates and target them for 
degradation (Tsai and Weissman, 2011). To study whether OS9 can be ubiquitinated 
by Hrd1, we overexpressed OS9.1 or OS9.2 with Hrd1 and Ub. MG132 was added 
to inhibit proteasome activity, allowing the detection of ubiquitinated substrates. Our 
data showed that both OS9.1 and OS9.2 were ubiquitinated. However, we noticed 
that the extent of ubiquitination may be different (Fig 2.4 D). A more intense smeared 
band indicated that OS9.1 may be ubiquitinated more efficiently than OS9.2 (Fig.2.4 
D). To confirm the ubiquitination of OS9, we then overexpressed OS9.1, Ub, Hrd1 
and immumopreticipated with HA (UB). Indeed, mono-ubiquitinated OS9.1 was 
presented in the IP sample (Fig.2.4 E). Hence, we concluded that OS9 can be 
ubiquitinated by Hrd1.    
         
Regulation of OS9 stability via the XBP1-Hrd1 signaling axis.   
 It is known that the IRE1α-XBP1 pathway of the UPR controls the expression 
of some ERAD genes (Alcock and Swanton, 2009; Bernasconi et al., 2008).  We 
next addressed whether the IRE1α-XBP1 pathway regulates the stability of OS9. To 
this end, we treated WT, IRE1α-/- and XBP1-/- cells with CHX to study the 
degradation rate of OS9.  Here we showed that the degradation of both OS9.1 and 
OS9.2 were attenuated in IRE1α-/- and XBP1-/- cells under CHX treatment (Fig 2.5A 
and B). In consistent with previous report that the IRE1α-XBP1 pathway regulate 
Hrd1, Hrd1 expression level was extremely low without the presence of XBP1, which 
may explain the attenuated degradation of OS9 in XBP1-/- cells compare to those of 
the WT cells. Since XBP can also transcriptionally induce OS9, the counter-intuitive 
finding of the increased OS9 basal protein level further suggests that OS9 is 
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degraded by the Sel1L-Hrd1 complex. Thus, our data suggest a dynamic 
regulation of OS9 stability through the XBP1-Hrd1 axis. 
 
Figure 2.5. Regulation of OS9 stability via the XBP1-Hrd1 axis. (A) OS9 half-life 
analysis in MEF cells treated with CHX at time 0, 1, 3 and 6hr. Darker exposure of 
OS9 blot is included to show the levels of OS9.1. Quantitation shown in (B) upon 




 Although previous study has speculated that the degradation of OS9 may 
depend on the Sel1L-Hrd1 ERAD complex (Tyler et al., 2012), this is the first study 
providing direct evidence of this hypothesis. Here we identified that OS9 is an 
endogenous ERAD substrate by manipulating cellular stress conditions and by 
depleting critical ERAD components Sel1L and Hrd1. Our data showed that OS9 is 
degraded under ER stress, but the degradation was blocked when proteasome was 
inhibited. In the absence of Sel1L and Hrd1, OS9 degradation was attenuated or 
abolished under CHX treatment, respectively. Our data further showed that OS9 is 
physically associated with Sel1L, and that it can also be ubiquitinated by Hrd1. 
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These data suggested that the degradation of OS9 is mediated by the Sel1L-Hrd1 
ERAD complex. Moreover, we found that the stability of OS9 is regulated through the 
the IRE1α-XBP1 pathway, suggesting a possible self-regulatory scheme of the 
Sel1L-Hrd1 complex. 
 OS9 was first found as a gene that is amplified in osteosarcoma with unknown 
function (Hosokawa et al., 2010a); however, it is now widely recognized that it is part 
of a large macromolecular ERAD complex that centered on Sel1l-Hrd1 (Christianson 
et al., 2008; Hosokawa et al., 2010a). The function of OS9 lies on its MRH domain, 
which recognizes specific trimmed glycan structures on ERAD substrates and bring 
them to the Sel1L-Hrd1 complex (Hosokawa et al., 2010a). Our data showed that 
either Sel1L or Hrd1 deficiency interfere with the degradation of OS9 both in cell 
lines and in mice, suggesting the dependence of OS9 degradation on Sel1L and 
Hrd1. Given that the transcription of OS9 was uncoupled with the increased protein 
level in IKO mice, it is highly possible that OS9 is degraded through the Sel1L-Hrd1 
complex. Previous study shows when Sel1L was depleted, OS9 strongly associated 
with identified endogenous substrate CD147 through its MRH domain (Tyler et al., 
2012). Together with our data, we suggest that OS9 may form a “suicidal” complex 
with substrates of the Sel1L-Hrd1 complex, followed by co-degradation.  
 This hypothesis explains that fact that OS9 is degraded under ER stress. 
Given the importance of OS9 in recognizing and delivering substrates to the Sel1L-
Hrd1 complex, it is intuitively unreasonable that it is degraded under ER stress, a 
situation where chaperones like OS9 are needed to degraded accumulated 
misfolded proteins and relieve ER stress. However, if OS9 is co-degraded with 
substrates, as we suggested, OS9 protein level should decrease. Given that OS9 is 
transcriptionally upregulated under ER stress (Alcock and Swanton, 2009; Sun et al., 
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2014), the turnover rate of OS9 seemed to be higher than that of the 
transcriptional regulation.  
 It is well established that Hrd1 is an E3 ligase that plays the most important 
role in the ubiquitination and degradation of substrates (Vembar and Brodsky, 2008). 
Our data herein showed that OS9 is ubiquitinated by the overexpression of Hrd1 and 
Ub, further supporting our hypothesis. Also, our data showed that the degradation of 
OS9 was completely abolished in Hrd1-/- MEFs, while that was only retarded in Sel1-
/- MEFs, suggesting Hrd1 is responsible for degrading OS9. In concordance with 
previous finding of our lab, we showed that Hrd1 protein level is drastically reduced 
in Sel1L-/- MEFs, suggesting Sel1L regulates the stability of Hrd1. Since Hrd1 was 
still presented in Sel1L-/- cells, OS9 could still be degraded at a slower rate. Taking 
together, we believe that the degradation of OS9 is mediated by Hrd1, while Sel1L 
plays a critical role in stabilizing Hrd1.  
 Besides stabling Hrd1, Sel1L is critical in physically bring OS9 to Hrd1, as 
previous studies and our data showed that OS9 interacts with Sel1L, but not with 
Hrd1(Hosokawa et al., 2010b; Satoh et al., 2010) Moreover, here we showed that 
OS9 interact with Sel1L in a glycosylation independent manner, suggesting the MRH 
domain of OS9 is not required for their interaction. This also suggests the possibility 
that OS9 may physically interact substrates at its MRH domain, and bring substrates 
to Hrd1 by physically interact with Sel1L at some other residues. Hence, our study 
also provides information on the mechanism of substrate degradation mediated by 
the OS9-Sel1L-Hrd1 pathway.  
 It is well known that UPR can induce the transcription of ERAD genes, such 
as Hrd1 and OS9, through the IRE1α-XBP signaling pathway (Alcock and Swanton, 
2009; Bernasconi et al., 2010). However, other regulatory pathways of ERAD 
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proteins may also exist. Here our data suggests that the absence of XBP1 
drastically decrease the expression of Hrd1, which in turn inhibits the degradation of 
OS9 and leads to the accumulation of OS9 in XBP1-/- cells. Hence, it is possible that 
OS9 is under the dual regulation of the IRE1α-XBP signaling pathway at the 
transcriptional level and the Sel1L-Hrd1 degradation pathway at protein level. If this 
finding is true, the regulation between UPR and ERAD, and within ERAD maybe 
more dynamic and complex than we once thought.       
 
2.6 Summary and Future Directions  
 In summary, our study identified a potential endogenous substrate of the 
Sel1L-Hrd1 complex. OS9, an effector involved in substrate recognition and 
recruitment of the Sel1L-Hrd1 complex, is itself a substrate of the exact same 
complex. Given the substrate-recruitment role of OS9, our data suggests that OS9 
may be co-degraded with other Se1lL-Hrd1 ERAD substrates by forming a complex 
with them. Hence, this study not only identifies an endogenous substrate for the 
Sel1L-Hrd1 complex, but also sheds light on the mechanism underlying substrate 
degradation, an area that is still need to be further investigated. Moreover, our data 
suggests that the regulation of OS9 is very dynamic and beyond the simple IRE1α-
XBP1 regulatory pathway, which may serves as a mechanism for the self-regulation 
of the Sel1L-Hrd1 complex. Hence, future studies should focus on 1) identifying 
substrates of the Sel1L-Hrd1 complex; and 2) studying the dynamics among 
substrates, OS9 and the Sel1L-Hrd1 complex, and 3) elucidating the intricate 
crosstalk between ERAD and UPR. We believe these studies will enrich our 
understanding on the maintenance of ER homeostasis.      
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   30	  
Reference 
 Acosta-­‐Alvear,	  D.,	  Zhou,	  Y.,	  Blais,	  A.,	  Tsikitis,	  M.,	  Lents,	  N.H.,	  Arias,	  C.,	  Lennon,	  C.J.,	  Kluger,	  Y.,	  and	  Dynlacht,	  B.D.	  (2007).	  XBP1	  controls	  diverse	  cell	  type-­‐	  and	  condition-­‐specific	  transcriptional	  regulatory	  networks.	  Molecular	  cell	  27,	  53-­‐66.	  Alcock,	  F.,	  and	  Swanton,	  E.	  (2009).	  Mammalian	  OS-­‐9	  is	  upregulated	  in	  response	  to	  endoplasmic	  reticulum	  stress	  and	  facilitates	  ubiquitination	  of	  misfolded	  glycoproteins.	  Journal	  of	  molecular	  biology	  385,	  1032-­‐1042.	  Bernasconi,	  R.,	  Galli,	  C.,	  Calanca,	  V.,	  Nakajima,	  T.,	  and	  Molinari,	  M.	  (2010).	  Stringent	  requirement	  for	  HRD1,	  SEL1L,	  and	  OS-­‐9/XTP3-­‐B	  for	  disposal	  of	  ERAD-­‐LS	  substrates.	  The	  Journal	  of	  cell	  biology	  188,	  223-­‐235.	  Bernasconi,	  R.,	  Pertel,	  T.,	  Luban,	  J.,	  and	  Molinari,	  M.	  (2008).	  A	  dual	  task	  for	  the	  Xbp1-­‐responsive	  OS-­‐9	  variants	  in	  the	  mammalian	  endoplasmic	  reticulum:	  inhibiting	  secretion	  of	  misfolded	  protein	  conformers	  and	  enhancing	  their	  disposal.	  The	  Journal	  of	  biological	  chemistry	  283,	  16446-­‐16454.	  Brodsky,	  J.L.,	  and	  Wojcikiewicz,	  R.J.	  (2009).	  Substrate-­‐specific	  mediators	  of	  ER	  associated	  degradation	  (ERAD).	  Current	  opinion	  in	  cell	  biology	  21,	  516-­‐521.	  Carvalho,	  P.,	  Goder,	  V.,	  and	  Rapoport,	  T.A.	  (2006).	  Distinct	  ubiquitin-­‐ligase	  complexes	  define	  convergent	  pathways	  for	  the	  degradation	  of	  ER	  proteins.	  Cell	  126,	  361-­‐373.	  Chen,	  H.,	  and	  Qi,	  L.	  (2010).	  SUMO	  modification	  regulates	  the	  transcriptional	  activity	  of	  XBP1.	  The	  Biochemical	  journal	  429,	  95-­‐102.	  Christianson,	  J.C.,	  Shaler,	  T.A.,	  Tyler,	  R.E.,	  and	  Kopito,	  R.R.	  (2008).	  OS-­‐9	  and	  GRP94	  deliver	  mutant	  alpha1-­‐antitrypsin	  to	  the	  Hrd1-­‐SEL1L	  ubiquitin	  ligase	  complex	  for	  ERAD.	  Nature	  cell	  biology	  10,	  272-­‐282.	  Coe,	  H.,	  and	  Michalak,	  M.	  (2010).	  ERp57,	  a	  multifunctional	  endoplasmic	  reticulum	  resident	  oxidoreductase.	  The	  international	  journal	  of	  biochemistry	  &	  cell	  biology	  42,	  796-­‐799.	  Denic,	  V.,	  Quan,	  E.M.,	  and	  Weissman,	  J.S.	  (2006).	  A	  luminal	  surveillance	  complex	  that	  selects	  misfolded	  glycoproteins	  for	  ER-­‐associated	  degradation.	  Cell	  126,	  349-­‐359.	  Ernst,	  R.,	  Mueller,	  B.,	  Ploegh,	  H.L.,	  and	  Schlieker,	  C.	  (2009).	  The	  otubain	  YOD1	  is	  a	  deubiquitinating	  enzyme	  that	  associates	  with	  p97	  to	  facilitate	  protein	  dislocation	  from	  the	  ER.	  Molecular	  cell	  36,	  28-­‐38.	  Ferrari,	  D.M.,	  and	  Soling,	  H.D.	  (1999).	  The	  protein	  disulphide-­‐isomerase	  family:	  unravelling	  a	  string	  of	  folds.	  The	  Biochemical	  journal	  339	  (	  Pt	  1),	  1-­‐10.	  Freedman,	  R.B.,	  Klappa,	  P.,	  and	  Ruddock,	  L.W.	  (2002).	  Protein	  disulfide	  isomerases	  exploit	  synergy	  between	  catalytic	  and	  specific	  binding	  domains.	  EMBO	  reports	  3,	  136-­‐140.	  Friedmann,	  E.,	  Salzberg,	  Y.,	  Weinberger,	  A.,	  Shaltiel,	  S.,	  and	  Gerst,	  J.E.	  (2002).	  YOS9,	  the	  putative	  yeast	  homolog	  of	  a	  gene	  amplified	  in	  osteosarcomas,	  is	  involved	  in	  the	  endoplasmic	  reticulum	  (ER)-­‐Golgi	  transport	  of	  GPI-­‐anchored	  proteins.	  The	  Journal	  of	  biological	  chemistry	  277,	  35274-­‐35281.	  Gauss,	  R.,	  Jarosch,	  E.,	  Sommer,	  T.,	  and	  Hirsch,	  C.	  (2006a).	  A	  complex	  of	  Yos9p	  and	  the	  HRD	  ligase	  integrates	  endoplasmic	  reticulum	  quality	  control	  into	  the	  degradation	  machinery.	  Nature	  cell	  biology	  8,	  849-­‐854.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   31	  Gauss,	  R.,	  Sommer,	  T.,	  and	  Jarosch,	  E.	  (2006b).	  The	  Hrd1p	  ligase	  complex	  forms	  a	  linchpin	  between	  ER-­‐lumenal	  substrate	  selection	  and	  Cdc48p	  recruitment.	  The	  EMBO	  journal	  25,	  1827-­‐1835.	  Haze,	  K.,	  Yoshida,	  H.,	  Yanagi,	  H.,	  Yura,	  T.,	  and	  Mori,	  K.	  (1999).	  Mammalian	  transcription	  factor	  ATF6	  is	  synthesized	  as	  a	  transmembrane	  protein	  and	  activated	  by	  proteolysis	  in	  response	  to	  endoplasmic	  reticulum	  stress.	  Molecular	  biology	  of	  the	  cell	  10,	  3787-­‐3799.	  Hebert,	  D.N.,	  and	  Molinari,	  M.	  (2007).	  In	  and	  out	  of	  the	  ER:	  protein	  folding,	  quality	  control,	  degradation,	  and	  related	  human	  diseases.	  Physiological	  reviews	  87,	  1377-­‐1408.	  Hirao,	  K.,	  Natsuka,	  Y.,	  Tamura,	  T.,	  Wada,	  I.,	  Morito,	  D.,	  Natsuka,	  S.,	  Romero,	  P.,	  Sleno,	  B.,	  Tremblay,	  L.O.,	  Herscovics,	  A.,	  et	  al.	  (2006).	  EDEM3,	  a	  soluble	  EDEM	  homolog,	  enhances	  glycoprotein	  endoplasmic	  reticulum-­‐associated	  degradation	  and	  mannose	  trimming.	  The	  Journal	  of	  biological	  chemistry	  281,	  9650-­‐9658.	  Hirsch,	  C.,	  Gauss,	  R.,	  Horn,	  S.C.,	  Neuber,	  O.,	  and	  Sommer,	  T.	  (2009).	  The	  ubiquitylation	  machinery	  of	  the	  endoplasmic	  reticulum.	  Nature	  458,	  453-­‐460.	  Horn,	  S.C.,	  Hanna,	  J.,	  Hirsch,	  C.,	  Volkwein,	  C.,	  Schutz,	  A.,	  Heinemann,	  U.,	  Sommer,	  T.,	  and	  Jarosch,	  E.	  (2009).	  Usa1	  functions	  as	  a	  scaffold	  of	  the	  HRD-­‐ubiquitin	  ligase.	  Molecular	  cell	  36,	  782-­‐793.	  Hosokawa,	  N.,	  Kamiya,	  Y.,	  Kamiya,	  D.,	  Kato,	  K.,	  and	  Nagata,	  K.	  (2009).	  Human	  OS-­‐9,	  a	  lectin	  required	  for	  glycoprotein	  endoplasmic	  reticulum-­‐associated	  degradation,	  recognizes	  mannose-­‐trimmed	  N-­‐glycans.	  The	  Journal	  of	  biological	  chemistry	  284,	  17061-­‐17068.	  Hosokawa,	  N.,	  Kamiya,	  Y.,	  and	  Kato,	  K.	  (2010a).	  The	  role	  of	  MRH	  domain-­‐containing	  lectins	  in	  ERAD.	  Glycobiology	  20,	  651-­‐660.	  Hosokawa,	  N.,	  Kato,	  K.,	  and	  Kamiya,	  Y.	  (2010b).	  Mannose	  6-­‐phosphate	  receptor	  homology	  domain-­‐containing	  lectins	  in	  mammalian	  endoplasmic	  reticulum-­‐associated	  degradation.	  Methods	  in	  enzymology	  480,	  181-­‐197.	  Hosokawa,	  N.,	  Wada,	  I.,	  Hasegawa,	  K.,	  Yorihuzi,	  T.,	  Tremblay,	  L.O.,	  Herscovics,	  A.,	  and	  Nagata,	  K.	  (2001).	  A	  novel	  ER	  alpha-­‐mannosidase-­‐like	  protein	  accelerates	  ER-­‐associated	  degradation.	  EMBO	  reports	  2,	  415-­‐422.	  Hosokawa,	  N.,	  Wada,	  I.,	  Nagasawa,	  K.,	  Moriyama,	  T.,	  Okawa,	  K.,	  and	  Nagata,	  K.	  (2008).	  Human	  XTP3-­‐B	  forms	  an	  endoplasmic	  reticulum	  quality	  control	  scaffold	  with	  the	  HRD1-­‐SEL1L	  ubiquitin	  ligase	  complex	  and	  BiP.	  The	  Journal	  of	  biological	  chemistry	  283,	  20914-­‐20924.	  Iida,	  Y.,	  Fujimori,	  T.,	  Okawa,	  K.,	  Nagata,	  K.,	  Wada,	  I.,	  and	  Hosokawa,	  N.	  (2011).	  SEL1L	  protein	  critically	  determines	  the	  stability	  of	  the	  HRD1-­‐SEL1L	  endoplasmic	  reticulum-­‐associated	  degradation	  (ERAD)	  complex	  to	  optimize	  the	  degradation	  kinetics	  of	  ERAD	  substrates.	  The	  Journal	  of	  biological	  chemistry	  286,	  16929-­‐16939.	  Ismail,	  N.,	  and	  Ng,	  D.T.	  (2006).	  Have	  you	  HRD?	  Understanding	  ERAD	  is	  DOAble!	  Cell	  126,	  237-­‐239.	  Kaneko,	  M.,	  Saito,	  R.,	  Okuma,	  Y.,	  and	  Nomura,	  Y.	  (2012).	  Possible	  involvement	  of	  ubiquitin	  ligase	  HRD1	  insolubilization	  in	  amyloid	  beta	  generation.	  Biological	  &	  pharmaceutical	  bulletin	  35,	  269-­‐272.	  Kaufman,	  R.J.,	  Scheuner,	  D.,	  Schroder,	  M.,	  Shen,	  X.,	  Lee,	  K.,	  Liu,	  C.Y.,	  and	  Arnold,	  S.M.	  (2002).	  The	  unfolded	  protein	  response	  in	  nutrient	  sensing	  and	  differentiation.	  Nature	  reviews	  Molecular	  cell	  biology	  3,	  411-­‐421.	  Kebache,	  S.,	  Cardin,	  E.,	  Nguyen,	  D.T.,	  Chevet,	  E.,	  and	  Larose,	  L.	  (2004).	  Nck-­‐1	  antagonizes	  the	  endoplasmic	  reticulum	  stress-­‐induced	  inhibition	  of	  translation.	  The	  Journal	  of	  biological	  chemistry	  279,	  9662-­‐9671.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   32	  Kim,	  W.,	  Spear,	  E.D.,	  and	  Ng,	  D.T.	  (2005).	  Yos9p	  detects	  and	  targets	  misfolded	  glycoproteins	  for	  ER-­‐associated	  degradation.	  Molecular	  cell	  19,	  753-­‐764.	  Kimura,	  Y.,	  Nakazawa,	  M.,	  and	  Yamada,	  M.	  (1998).	  Cloning	  and	  characterization	  of	  three	  isoforms	  of	  OS-­‐9	  cDNA	  and	  expression	  of	  the	  OS-­‐9	  gene	  in	  various	  human	  tumor	  cell	  lines.	  Journal	  of	  biochemistry	  123,	  876-­‐882.	  Lilley,	  B.N.,	  and	  Ploegh,	  H.L.	  (2005).	  Multiprotein	  complexes	  that	  link	  dislocation,	  ubiquitination,	  and	  extraction	  of	  misfolded	  proteins	  from	  the	  endoplasmic	  reticulum	  membrane.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  102,	  14296-­‐14301.	  Malhotra,	  J.D.,	  and	  Kaufman,	  R.J.	  (2007).	  The	  endoplasmic	  reticulum	  and	  the	  unfolded	  protein	  response.	  Seminars	  in	  cell	  &	  developmental	  biology	  18,	  716-­‐731.	  Maruyama,	  Y.,	  Yamada,	  M.,	  Takahashi,	  K.,	  and	  Yamada,	  M.	  (2008).	  Ubiquitin	  ligase	  Kf-­‐1	  is	  involved	  in	  the	  endoplasmic	  reticulum-­‐associated	  degradation	  pathway.	  Biochemical	  and	  biophysical	  research	  communications	  374,	  737-­‐741.	  Mast,	  S.W.,	  Diekman,	  K.,	  Karaveg,	  K.,	  Davis,	  A.,	  Sifers,	  R.N.,	  and	  Moremen,	  K.W.	  (2005).	  Human	  EDEM2,	  a	  novel	  homolog	  of	  family	  47	  glycosidases,	  is	  involved	  in	  ER-­‐associated	  degradation	  of	  glycoproteins.	  Glycobiology	  15,	  421-­‐436.	  Matlack,	  K.E.,	  Mothes,	  W.,	  and	  Rapoport,	  T.A.	  (1998).	  Protein	  translocation:	  tunnel	  vision.	  Cell	  92,	  381-­‐390.	  McCracken,	  A.A.,	  and	  Brodsky,	  J.L.	  (1996).	  Assembly	  of	  ER-­‐associated	  protein	  degradation	  in	  vitro:	  dependence	  on	  cytosol,	  calnexin,	  and	  ATP.	  The	  Journal	  of	  cell	  biology	  132,	  291-­‐298.	  Mehnert,	  M.,	  Sommer,	  T.,	  and	  Jarosch,	  E.	  (2010).	  ERAD	  ubiquitin	  ligases:	  multifunctional	  tools	  for	  protein	  quality	  control	  and	  waste	  disposal	  in	  the	  endoplasmic	  reticulum.	  BioEssays	  :	  news	  and	  reviews	  in	  molecular,	  cellular	  and	  developmental	  biology	  32,	  905-­‐913.	  Mendes,	  C.C.,	  Gomes,	  D.A.,	  Thompson,	  M.,	  Souto,	  N.C.,	  Goes,	  T.S.,	  Goes,	  A.M.,	  Rodrigues,	  M.A.,	  Gomez,	  M.V.,	  Nathanson,	  M.H.,	  and	  Leite,	  M.F.	  (2005).	  The	  type	  III	  inositol	  1,4,5-­‐trisphosphate	  receptor	  preferentially	  transmits	  apoptotic	  Ca2+	  signals	  into	  mitochondria.	  The	  Journal	  of	  biological	  chemistry	  280,	  40892-­‐40900.	  Molinari,	  M.	  (2007).	  N-­‐glycan	  structure	  dictates	  extension	  of	  protein	  folding	  or	  onset	  of	  disposal.	  Nature	  chemical	  biology	  3,	  313-­‐320.	  Molinari,	  M.,	  Calanca,	  V.,	  Galli,	  C.,	  Lucca,	  P.,	  and	  Paganetti,	  P.	  (2003).	  Role	  of	  EDEM	  in	  the	  release	  of	  misfolded	  glycoproteins	  from	  the	  calnexin	  cycle.	  Science	  299,	  1397-­‐1400.	  Mueller,	  B.,	  Klemm,	  E.J.,	  Spooner,	  E.,	  Claessen,	  J.H.,	  and	  Ploegh,	  H.L.	  (2008).	  SEL1L	  nucleates	  a	  protein	  complex	  required	  for	  dislocation	  of	  misfolded	  glycoproteins.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  105,	  12325-­‐12330.	  Munro,	  S.	  (2001).	  The	  MRH	  domain	  suggests	  a	  shared	  ancestry	  for	  the	  mannose	  6-­‐phosphate	  receptors	  and	  other	  N-­‐glycan-­‐recognising	  proteins.	  Current	  biology	  :	  CB	  11,	  R499-­‐501.	  Oda,	  Y.,	  Hosokawa,	  N.,	  Wada,	  I.,	  and	  Nagata,	  K.	  (2003).	  EDEM	  as	  an	  acceptor	  of	  terminally	  misfolded	  glycoproteins	  released	  from	  calnexin.	  Science	  299,	  1394-­‐1397.	  Olivari,	  S.,	  Galli,	  C.,	  Alanen,	  H.,	  Ruddock,	  L.,	  and	  Molinari,	  M.	  (2005).	  A	  novel	  stress-­‐induced	  EDEM	  variant	  regulating	  endoplasmic	  reticulum-­‐associated	  glycoprotein	  degradation.	  The	  Journal	  of	  biological	  chemistry	  280,	  2424-­‐2428.	  Parodi,	  A.J.	  (2000).	  Protein	  glucosylation	  and	  its	  role	  in	  protein	  folding.	  Annual	  review	  of	  biochemistry	  69,	  69-­‐93.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   33	  Parodi,	  A.J.,	  Behrens,	  N.H.,	  Leloir,	  L.F.,	  and	  Carminatti,	  H.	  (1972).	  The	  role	  of	  polyprenol-­‐bound	  saccharides	  as	  intermediates	  in	  glycoprotein	  synthesis	  in	  liver.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  69,	  3268-­‐3272.	  Pearse,	  B.R.,	  Tamura,	  T.,	  Sunryd,	  J.C.,	  Grabowski,	  G.A.,	  Kaufman,	  R.J.,	  and	  Hebert,	  D.N.	  (2010).	  The	  role	  of	  UDP-­‐Glc:glycoprotein	  glucosyltransferase	  1	  in	  the	  maturation	  of	  an	  obligate	  substrate	  prosaposin.	  The	  Journal	  of	  cell	  biology	  189,	  829-­‐841.	  Richly,	  H.,	  Rape,	  M.,	  Braun,	  S.,	  Rumpf,	  S.,	  Hoege,	  C.,	  and	  Jentsch,	  S.	  (2005).	  A	  series	  of	  ubiquitin	  binding	  factors	  connects	  CDC48/p97	  to	  substrate	  multiubiquitylation	  and	  proteasomal	  targeting.	  Cell	  120,	  73-­‐84.	  Roberts,	  D.L.,	  Weix,	  D.J.,	  Dahms,	  N.M.,	  and	  Kim,	  J.J.	  (1998).	  Molecular	  basis	  of	  lysosomal	  enzyme	  recognition:	  three-­‐dimensional	  structure	  of	  the	  cation-­‐dependent	  mannose	  6-­‐phosphate	  receptor.	  Cell	  93,	  639-­‐648.	  Ron,	  D.,	  and	  Walter,	  P.	  (2007).	  Signal	  integration	  in	  the	  endoplasmic	  reticulum	  unfolded	  protein	  response.	  Nature	  reviews	  Molecular	  cell	  biology	  8,	  519-­‐529.	  Satoh,	  T.,	  Chen,	  Y.,	  Hu,	  D.,	  Hanashima,	  S.,	  Yamamoto,	  K.,	  and	  Yamaguchi,	  Y.	  (2010).	  Structural	  basis	  for	  oligosaccharide	  recognition	  of	  misfolded	  glycoproteins	  by	  OS-­‐9	  in	  ER-­‐associated	  degradation.	  Molecular	  cell	  40,	  905-­‐916.	  Shen,	  X.,	  Zhang,	  K.,	  and	  Kaufman,	  R.J.	  (2004).	  The	  unfolded	  protein	  response-­‐-­‐a	  stress	  signaling	  pathway	  of	  the	  endoplasmic	  reticulum.	  Journal	  of	  chemical	  neuroanatomy	  28,	  79-­‐92.	  Smith,	  M.H.,	  Ploegh,	  H.L.,	  and	  Weissman,	  J.S.	  (2011).	  Road	  to	  ruin:	  targeting	  proteins	  for	  degradation	  in	  the	  endoplasmic	  reticulum.	  Science	  334,	  1086-­‐1090.	  Stagg,	  H.R.,	  Thomas,	  M.,	  van	  den	  Boomen,	  D.,	  Wiertz,	  E.J.,	  Drabkin,	  H.A.,	  Gemmill,	  R.M.,	  and	  Lehner,	  P.J.	  (2009).	  The	  TRC8	  E3	  ligase	  ubiquitinates	  MHC	  class	  I	  molecules	  before	  dislocation	  from	  the	  ER.	  The	  Journal	  of	  cell	  biology	  186,	  685-­‐692.	  Sun,	  S.,	  Shi,	  G.,	  Han,	  X.,	  Francisco,	  A.B.,	  Ji,	  Y.,	  Mendonca,	  N.,	  Liu,	  X.,	  Locasale,	  J.W.,	  Simpson,	  K.W.,	  Duhamel,	  G.E.,	  et	  al.	  (2014).	  Sel1L	  is	  indispensable	  for	  mammalian	  endoplasmic	  reticulum-­‐associated	  degradation,	  endoplasmic	  reticulum	  homeostasis,	  and	  survival.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  111,	  E582-­‐591.	  Tsai,	  Y.C.,	  and	  Weissman,	  A.M.	  (2011).	  Ubiquitylation	  in	  ERAD:	  reversing	  to	  go	  forward?	  PLoS	  biology	  9,	  e1001038.	  Tyler,	  R.E.,	  Pearce,	  M.M.,	  Shaler,	  T.A.,	  Olzmann,	  J.A.,	  Greenblatt,	  E.J.,	  and	  Kopito,	  R.R.	  (2012).	  Unassembled	  CD147	  is	  an	  endogenous	  endoplasmic	  reticulum-­‐associated	  degradation	  substrate.	  Molecular	  biology	  of	  the	  cell	  23,	  4668-­‐4678.	  Ushioda,	  R.,	  Hoseki,	  J.,	  and	  Nagata,	  K.	  (2013).	  Glycosylation-­‐independent	  ERAD	  pathway	  serves	  as	  a	  backup	  system	  under	  ER	  stress.	  Molecular	  biology	  of	  the	  cell	  24,	  3155-­‐3163.	  Vembar,	  S.S.,	  and	  Brodsky,	  J.L.	  (2008).	  One	  step	  at	  a	  time:	  endoplasmic	  reticulum-­‐associated	  degradation.	  Nature	  reviews	  Molecular	  cell	  biology	  9,	  944-­‐957.	  Wahlman,	  J.,	  DeMartino,	  G.N.,	  Skach,	  W.R.,	  Bulleid,	  N.J.,	  Brodsky,	  J.L.,	  and	  Johnson,	  A.E.	  (2007).	  Real-­‐time	  fluorescence	  detection	  of	  ERAD	  substrate	  retrotranslocation	  in	  a	  mammalian	  in	  vitro	  system.	  Cell	  129,	  943-­‐955.	  Walter,	  P.,	  and	  Ron,	  D.	  (2011).	  The	  unfolded	  protein	  response:	  from	  stress	  pathway	  to	  homeostatic	  regulation.	  Science	  334,	  1081-­‐1086.	  Xu,	  C.,	  Wang,	  S.,	  Thibault,	  G.,	  and	  Ng,	  D.T.	  (2013).	  Futile	  protein	  folding	  cycles	  in	  the	  ER	  are	  terminated	  by	  the	  unfolded	  protein	  O-­‐mannosylation	  pathway.	  Science	  340,	  978-­‐981.	  























	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Shu	   35	  
Supplement 
Table S1: Primer Sequences used in this study 




flox/flox CTGACTGAGGAAGGGTCTC GCTAAAAACATTACAAAGGGGCA 




sel1l TGGGTTTTCTCTCTCTCCTCTG CCTTTGTTCCGGTTACTTCTTG 
os9 GCTGGCTGACTGATGAGGAT CGGTAGTTGCTCTCCAGCTC 
l32 GAGCAACAAGAAAACCAAGCA TGCACACAAGCCATCTACTCA 
Mutagenes
is primers 
  
Sel1L 
(N191Q) CCGGGATGAAGATACTGCAGGGAAGCAATAGGAAGAG 
CTCTTCCTATTGCTTCCCTGCAGTATCTTCATC
CCGG 
Sel1L 
(N213Q) GAAGGCAGCAGGCATGCAGCACACCAAAGCCCTG 
CAGGGCTTTGGTGTGCTGCATGCCTGCTGCCT
TC 
Sel1L 
(N268Q) CTTCTGGGCTTGGTGTTCAGTCAAGTCAGGCAAAGG 
CCTTTGCCTGACTTGACTGAACACCAAGCCCA
GAAG 
Sel1L 
(N427Q) CATCGTACCTCAGAGTCAGGAGACGGCACTTCAC 
GTGAAGTGCCGTCTCCTGACTCTGAGGTACGA
TG 
Sel1L 
(N604Q) CAACCATTGTAGGTGAGcAGGAAACTTACCCCAGAGC 
GCTCTGGGGTAAGTTTCCTGCTCACCTACAATG
GTTG 	  
